Sign in
Time to Retinal Fluid Control With Faricimab vs Aflibercept in Patients With DME in the Phase 3 YOSEMITE/RHINE Trials
Aleksandra V. Rachitskaya, MD, FASRS
Annual Meeting Talks
2023
Phase 2a Study of CU06-1004, an Oral Endothelial Dysfunction Blocker for the Treatment of Diabetic Macular Edema
Victor Hugo Gonzalez, MD
Updates from the Field
2024
Delayed and Loss of Follow-Up in Patients Receiving Intravitreal Injections for Diabetic Macular Edema
Jason Hsu, MD
On Demand Cases, Courses, and Papers
2017
Category: Socioeconomics